Literature DB >> 19997061

Retro-orbital injection in adult zebrafish.

Emily K Pugach1, Pulin Li, Richard White, Leonard Zon.   

Abstract

Drug treatment of whole animals is an essential tool in any model system for pharmacological and chemical genetic studies. Intravenous (IV) injection is often the most effective and noninvasive form of delivery of an agent of interest. In the zebrafish (Danio rerio), IV injection of drugs has long been a challenge because of the small vessel diameter. This has also proved a significant hurdle for the injection of cells during hematopoeitic stem cell transplantation. Historically, injections into the bloodstream were done directly through the heart. However, this intra-cardiac procedure has a very high mortality rate as the heart is often punctured during injection leaving the fish prone to infection, massive blood loss or fatal organ damage. Drawing on our experience with the mouse, we have developed a new injection procedure in the zebrafish in which the injection site is behind the eye and into the retro-orbital venous sinus. This retro-orbital (RO) injection technique has been successfully employed in both the injection of drugs in the adult fish as well as transplantation of whole kidney marrow cells. RO injection has a much lower mortality rate than traditional intra-cardiac injection. Fish that are injected retro-orbitally tend to bleed less following injection and are at a much lower risk of injury to a major organ like the heart. Further, when performed properly, injected cells and/or drugs quickly enter the bloodstream allowing compounds to exert their effect on the whole fish and kidney cells to easily home to their niche. Thus, this new injection technique minimizes mortality while allowing efficient delivery of material into the bloodstream of adult fish. Here we exemplify this technique by retro-orbital injection of Tg(globin:GFP) cells into adult casper fish as well as injection of a red fluorescent dye (dextran, Texas Red ) into adult casper fish. We then visualize successful injections by whole animal fluorescence microscopy.

Entities:  

Mesh:

Year:  2009        PMID: 19997061      PMCID: PMC3149973          DOI: 10.3791/1645

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  4 in total

1.  A METHOD OF INJECTING SMALL LABORATORY ANIMALS BY THE OPHTHALMIC PLEXUS ROUTE.

Authors:  W PINKERTON; M WEBBER
Journal:  Proc Soc Exp Biol Med       Date:  1964 Aug-Sep

2.  Transplantation of whole kidney marrow in adult zebrafish.

Authors:  Jocelyn LeBlanc; Teresa Venezia Bowman; Leonard Zon
Journal:  J Vis Exp       Date:  2007-02-25       Impact factor: 1.355

3.  Comparison of the lateral tail vein and the retro-orbital venous sinus as routes of intravenous drug delivery in a transgenic mouse model.

Authors:  Christina D Steel; Amber L Stephens; Suzanne M Hahto; Sylvia J Singletary; Richard P Ciavarra
Journal:  Lab Anim (NY)       Date:  2008-01       Impact factor: 12.625

4.  Transparent adult zebrafish as a tool for in vivo transplantation analysis.

Authors:  Richard Mark White; Anna Sessa; Christopher Burke; Teresa Bowman; Jocelyn LeBlanc; Craig Ceol; Caitlin Bourque; Michael Dovey; Wolfram Goessling; Caroline Erter Burns; Leonard I Zon
Journal:  Cell Stem Cell       Date:  2008-02-07       Impact factor: 24.633

  4 in total
  41 in total

1.  An optical platform for cell tracking in adult zebrafish.

Authors:  Li Zhang; Clemens Alt; Pulin Li; Richard M White; Leonard I Zon; Xunbin Wei; Charles P Lin
Journal:  Cytometry A       Date:  2011-12-07       Impact factor: 4.355

2.  Blood collection for biochemical analysis in adult zebrafish.

Authors:  Gabriela L Pedroso; Thais O Hammes; Thayssa D C Escobar; Laisa B Fracasso; Luiz Felipe Forgiarini; Themis R da Silveira
Journal:  J Vis Exp       Date:  2012-05-26       Impact factor: 1.355

Review 3.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

4.  High frequency photoacoustic imaging for in vivo visualizing blood flow of zebrafish heart.

Authors:  Jinhyoung Park; Thomas M Cummins; Michael Harrison; Jungwoo Lee; Qifa Zhou; Ching-Ling Lien; K Kirk Shung
Journal:  Opt Express       Date:  2013-06-17       Impact factor: 3.894

5.  zebraflash transgenic lines for in vivo bioluminescence imaging of stem cells and regeneration in adult zebrafish.

Authors:  Chen-Hui Chen; Ellen Durand; Jinhu Wang; Leonard I Zon; Kenneth D Poss
Journal:  Development       Date:  2013-11-06       Impact factor: 6.868

6.  Extracellular component hyaluronic acid and its receptor Hmmr are required for epicardial EMT during heart regeneration.

Authors:  Maria A Missinato; Kimimasa Tobita; Nicla Romano; James A Carroll; Michael Tsang
Journal:  Cardiovasc Res       Date:  2015-07-07       Impact factor: 10.787

7.  Zebrafish model for allogeneic hematopoietic cell transplantation not requiring preconditioning.

Authors:  Isabell Hess; Norimasa Iwanami; Michael Schorpp; Thomas Boehm
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

8.  Characterization of immune-matched hematopoietic transplantation in zebrafish.

Authors:  Jill L O de Jong; Caroline Erter Burns; Aye T Chen; Emily Pugach; Elizabeth A Mayhall; Alexandra C H Smith; Henry A Feldman; Yi Zhou; Leonard I Zon
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

9.  Translational profiling of cardiomyocytes identifies an early Jak1/Stat3 injury response required for zebrafish heart regeneration.

Authors:  Yi Fang; Vikas Gupta; Ravi Karra; Jennifer E Holdway; Kazu Kikuchi; Kenneth D Poss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-30       Impact factor: 11.205

Review 10.  Genetic and environmental melanoma models in fish.

Authors:  E Elizabeth Patton; David L Mitchell; Rodney S Nairn
Journal:  Pigment Cell Melanoma Res       Date:  2010-03-08       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.